2H-Benzimidazol-2-one, 1,3-dihydro-5-[3-[4-(phenylmethyl)-1-piperidinyl]-1-propyn-1-yl]-, 98%, 5mg

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-1-amine, 95%, 250mg

1-Methylpyrazole-5-methanol>98.0%(GC)(T)1g

N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANESULFONAMIDE, 95%, 100mg

17-Bromoheptadecanoic acid, 250mg

1-(Pyridin-3-yl)piperazine dihydrochloride, 95.0%, 5g

(4-Isopropylphenyl)(pyridin-4-yl)methanone, 95%, 100mg

1,2-Bis(4-methoxyphenyl)-2-oxoethyl cyclohexylcarbamate, 98%, 1g

ethyl 3-{[2-(1H-indol-3-yl)ethyl]amino}propanoate, 95.0%, 10g

Vinyl terminated polydimethylsiloxane cSt 3500, 100g

3-((4-(tert-butyl)phenyl)sulfonamido)propanoic acid, 95.0%, 2.5g

(4S,4'S)-4,4'-Di((S)-sec-butyl)-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

5-(2-ethoxyphenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 2g